Regional Spotlight: MAGDEBURG

In our new “Regional Spotlight” series, Markets Germany profiles attractive German investment locations as well as industry and research clusters. Our first candidate is the Magdeburg region, where the Max Planck Institute (MPI) researches chemical systems engineering, bioprocess technology and energy systems.

May 2021

Health technology blooms  in Magdeburg

The city of Magdeburg in eastern Germany, just a 90-minute drive from Berlin, is facing momentous change. In recent years, the capital of Saxony-Anhalt has blossomed into a healthtech hotspot. Several dozen healthtech and pharmaceutical companies have settled there – including some notable international players. One example is Salutas Pharma, a division of the Novartis group, which is now a major employer in the region and one of many companies from abroad capitalizing on the growing opportunities in the healthtech cluster.

One of the major attractions of Magdeburg is the presence of a Max Planck Institute and a network of research centers. Already in 2018, for example, the institute launched a technology that vastly accelerates the production of virus vaccines. In a world that is adapting to coronavirus, having access to that kind of expertise is a distinct advantage for healthcare firms.

At the Max Planck Institute for Dynamics of Complex Technical Systems, located in Magdeburg, scientists i.a. are running
tests to determine how glycosylation of the spike protein of SARS-CoV-2 will impact the capacity of the virus to cause
disease in humans. Their findings are a valuable contribution to the pool of research focused on developing effective
vaccines. © Stefan Deutsch/MPI Magdeburg